Development of a Simple and Quick Method to Assess Base Editing in Human Cells

Base editing is a form of genome editing that can directly convert a single base (C or A) to another base (T or G), which is of great potential in biomedical applications. The broad application of base editing is limited by its low activity and specificity, which still needs to be resolved. To address this, a simple and quick method for the determination of its activity/specificity is highly desired. Here, we developed a novel system, which could be harnessed for quick detection of editing activity and specificity of base editors (BEs) in human cells. Specifically, multiple cloning sites (MCS) were inserted into the human genome via lentivirus, and base editing targeting the MCS was performed with BEs. The base editing activities were assessed by specific restriction enzymes. The whole process only includes nucleotide-based targeting the MCS, editing, PCR, and digestion, thus, we named it NOTEPAD. This straightforward approach could be easily accessed by molecular biology laboratories. With this method, we could easily determine the BEs editing efficiency and pattern. The results revealed that BEs triggered more off-target effects in the genome than on plasmids including genomic indels (insertions and deletions). We found that ABEs (adenine base editors) had better fidelity than CBEs (cytosine base editors). Our system could be harnessed as a base editing assessment platform, which would pave the way for the development of next-generation BEs.

[1]  David R. Liu,et al.  Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage , 2016, Nature.

[2]  Richard Heller,et al.  Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[3]  Yunde Zhao,et al.  Generation of Targeted Point Mutations in Rice by a Modified CRISPR/Cas9 System. , 2017, Molecular plant.

[4]  David R. Liu,et al.  Evolved Cas9 variants with broad PAM compatibility and high DNA specificity , 2018, Nature.

[5]  Chantal Pichon,et al.  Chemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers , 2009, British journal of pharmacology.

[6]  Huijue Jia,et al.  AID/APOBEC deaminases disfavor modified cytosines implicated in DNA demethylation , 2012, Nature chemical biology.

[7]  Dan Liu,et al.  Genome-wide profiling of adenine base editor specificity by EndoV-seq , 2019, Nature Communications.

[8]  Bing Yang,et al.  Highly Efficient A·T to G·C Base Editing by Cas9n-Guided tRNA Adenosine Deaminase in Rice. , 2018, Molecular plant.

[9]  R. Kanaar,et al.  DNA double-strand break repair: all's well that ends well. , 2006, Annual review of genetics.

[10]  Kevin T. Zhao,et al.  Improved base excision repair inhibition and bacteriophage Mu Gam protein yields C:G-to-T:A base editors with higher efficiency and product purity , 2017, Science Advances.

[11]  G. Csonka,et al.  Features of the interactions between the methyl-CpG motif and the arginine residues on the surface of MBD proteins , 2016, Structural Chemistry.

[12]  Jian‐Kang Zhu,et al.  Precise Editing of a Target Base in the Rice Genome Using a Modified CRISPR/Cas9 System. , 2017, Molecular plant.

[13]  Eugene Chung,et al.  Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy , 2018, Nature Biotechnology.

[14]  David R. Liu,et al.  Editing the Genome Without Double-Stranded DNA Breaks. , 2017, ACS chemical biology.

[15]  Feng Gu,et al.  Efficient Human Genome Editing Using SaCas9 Ribonucleoprotein Complexes. , 2019, Biotechnology journal.

[16]  Dan Liu,et al.  Correction of β-thalassemia mutant by base editor in human embryos , 2017, Protein & Cell.

[17]  Luigi Naldini,et al.  Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics , 2001, Nature Medicine.

[18]  Gaelen T. Hess,et al.  Directed evolution using dCas9-targeted somatic hypermutation in mammalian cells , 2016, Nature Methods.

[19]  A. Knudson,et al.  Endogenous DNA double-strand breaks: Production, fidelity of repair, and induction of cancer , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Charles A Gersbach,et al.  Enabling functional genomics with genome engineering , 2015, Genome research.

[21]  David A. Brafman,et al.  The Impact of Chromatin Dynamics on Cas9-Mediated Genome Editing in Human Cells. , 2017, ACS synthetic biology.

[22]  Dana Carroll,et al.  Nucleosomes inhibit target cleavage by CRISPR-Cas9 in vivo , 2018, Proceedings of the National Academy of Sciences.

[23]  C. Li,et al.  Expanded base editing in rice and wheat using a Cas9-adenosine deaminase fusion , 2018, Genome Biology.

[24]  David R. Liu,et al.  Aptazyme-embedded guide RNAs enable ligand-responsive genome editing and transcriptional activation , 2017, Nature Communications.

[25]  Mingyao Liu,et al.  Correction to: Increasing targeting scope of adenosine base editors in mouse and rat embryos through fusion of TadA deaminase with Cas9 variants , 2018, Protein & Cell.

[26]  Le Cong,et al.  Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.

[27]  Junhao Fu,et al.  A ‘new lease of life’: FnCpf1 possesses DNA cleavage activity for genome editing in human cells , 2017, Nucleic acids research.

[28]  David R. Liu,et al.  Improving the DNA specificity and applicability of base editing through protein engineering and protein delivery , 2017, Nature Communications.

[29]  Hao Yin,et al.  Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype , 2014, Nature Biotechnology.

[30]  Mingyao Liu,et al.  Increasing targeting scope of adenosine base editors in mouse and rat embryos through fusion of TadA deaminase with Cas9 variants , 2018, Protein & Cell.

[31]  Feng Gu,et al.  Comparison of non-canonical PAMs for CRISPR/Cas9-mediated DNA cleavage in human cells , 2014, Scientific Reports.

[32]  David R. Liu,et al.  Continuous evolution of base editors with expanded target compatibility and improved activity , 2019, Nature Biotechnology.

[33]  Hao Yin,et al.  Delivery technologies for genome editing , 2017, Nature Reviews Drug Discovery.

[34]  Li Yang,et al.  Efficient base editing in methylated regions with a human APOBEC3A-Cas9 fusion , 2018, Nature Biotechnology.

[35]  L. Steinmetz,et al.  Cytosine base editor generates substantial off-target single-nucleotide variants in mouse embryos , 2019, Science.

[36]  Q. Gao,et al.  Cytosine, but not adenine, base editors induce genome-wide off-target mutations in rice , 2019, Science.

[37]  Yan Song,et al.  Targeted AID-mediated mutagenesis (TAM) enables efficient genomic diversification in mammalian cells , 2016, Nature Methods.

[38]  Kristopher T. Jensen,et al.  Chromatin accessibility and guide sequence secondary structure affect CRISPR‐Cas9 gene editing efficiency , 2017, FEBS letters.

[39]  Nicole M. Gaudelli,et al.  Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage , 2017, Nature.

[40]  Shuo Lin,et al.  TALEN-mediated precise genome modification by homologous recombination in zebrafish , 2013, Nature Methods.

[41]  Qiang Sun,et al.  Efficient generation of mouse models of human diseases via ABE- and BE-mediated base editing , 2018, Nature Communications.

[42]  Junjiu Huang,et al.  Effective and precise adenine base editing in mouse zygotes , 2018, Protein & Cell.

[43]  David J. Chen,et al.  DNA double strand break repair via non-homologous end-joining. , 2013, Translational cancer research.

[44]  David R. Liu,et al.  CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes , 2017, Cell.

[45]  G. Church,et al.  CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering , 2013, Nature Biotechnology.

[46]  A. Kondo,et al.  Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems , 2016, Science.

[47]  Kevin T. Zhao,et al.  Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions , 2017, Nature Biotechnology.

[48]  Christopher J. Cheng,et al.  In vivo correction of anaemia in β-thalassemic mice by γPNA-mediated gene editing with nanoparticle delivery , 2016, Nature Communications.

[49]  Rui Zhang,et al.  Precise base editing in rice, wheat and maize with a Cas9-cytidine deaminase fusion , 2017, Nature Biotechnology.

[50]  Jia Li,et al.  Genetic Modulation of RNA Splicing with a CRISPR-Guided Cytidine Deaminase. , 2018, Molecular cell.